Sharekhan

Amanta Healthcare Ltd

Tue 17/02/2026,15:49:1 | NSE : AMANTA

₹ 108.395.28 (5.12%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 103.11

Previous Close

₹ 103.11

Volume

182146

Mkt Cap ( Rs. Cr)

₹420.87

High

₹ 109.00

Low

₹ 103.11

52 Week High

₹ 154.40

52 Week Low

₹ 97.75

Book Value Per Share

₹ 54.26

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Amanta Healthcare Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

108.39

30

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

30

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Amanta Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Credit Rating

    16 Feb 2026, 4:29PM Announcement under Regulation 30 (LODR) - Credit Rating
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    16 Feb 2026, 2:33PM Announcement under Regulation 30 (LODR) - Earnings Call Transcript
  • Amanta Healthcare - Monitoring Agency Report

    14 Feb 2026, 1:51PM Submission of Monitoring Agency Report Q3 2025-26
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    14 Feb 2026, 1:48PM Announcement under Regulation 30 (LODR) - Monitoring Agency Report
  • Amanta Healthcare - General Updates

    12 Feb 2026, 2:13PM Amanta Healthcare Limited has informed the Exchange about copy of newspaper publication
  • Amanta Healthcare - Copy Of Newspaper Publication

    12 Feb 2026, 2:09PM Newspaper Publication of the unaudited Financial Results for the Quarter ended December 31, 2025.
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Feb 2026, 5:47PM Amanta Healthcare Limited has informed the Exchange about Link of Recording
  • Amanta Healthcare - General Updates

    11 Feb 2026, 2:25PM Amanta Healthcare Limited has informed the Exchange about Investor Presentation
  • Amanta Healthcare - Press Release

    11 Feb 2026, 1:55PM Amanta Healthcare Limited has informed the Exchange regarding a press release dated February 11, 2026, titled ""Amanta Healthcare Limited announces Q3
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    11 Feb 2026, 5:44PM Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation

    11 Feb 2026, 2:22PM Earnings presentation pertaining to unaudited financial results of quarter and nine-month period ended December 31, 2025
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    11 Feb 2026, 1:52PM Announcement under Regulation 30_press release
  • Amanta Healthcare - Outcome of Board Meeting

    10 Feb 2026, 1:46PM Amanta Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
  • Amanta Healthcare - Change in Management

    10 Feb 2026, 1:15PM Amanta Healthcare Limited has informed the Exchange about change in Senior Management Personnel of the Company
  • Amanta Healthcare Q3 net profit jumps 74.72% at Rs 4.63 cr

    10 Feb 2026, 5:30PM The company reported standalone net profit of Rs 4.63 crore for the quarter ended December 31, 2025 as compared to Rs 2.65 crore in the same period la
  • Amanta Healthcare - Board Meeting Outcome for Unaudited Financial Results For Q3 Of FY 2025-26

    10 Feb 2026, 1:34PM Outcome of Board Meeting
  • Amanta Healthcare - Unaudited Financial Results For Q3 Of FY 2025-26

    10 Feb 2026, 1:28PM Unaudited Financial Results for Q3 of FY 2025-26
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Change in Management

    10 Feb 2026, 1:12PM Intimation for change in Senior Management Personnel (SMP) of the Company
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Feb 2026, 9:30PM Amanta Healthcare Limited has informed the Exchange about Schedule of meet
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Feb 2026, 9:24PM Intimation of schedule of the Earnings conference call for Q3 and nine months of FY 2025-26
  • Amanta Healthcare - Updates

    2 Feb 2026, 11:43AM Amanta Healthcare Limited has informed the Exchange regarding 'Intimation of opening of special window for transfer and dematerialisation of physical
  • Amanta Healthcare - Board Meeting Intimation for To Approve Unaudited Financial Results For Quarter Ended December 31, 2025.

    2 Feb 2026, 12:17PM Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider an
  • Amanta Healthcare - Intimation Of Opening Of Special Window For Transfer And Dematerialisation Of Physical Securities.

    2 Feb 2026, 11:39AM Intimation of opening of special window for transfer and Dematerialisation of physical securities.
  • Amanta Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    20 Jan 2026, 3:30PM As of December 2025, 63.56% is owned by Promoters and 36.44% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 26.65% and F
  • Amanta Healthcare - General Updates

    10 Jan 2026, 11:49AM Amanta Healthcare Limited has informed the Exchange about General Updates
  • Amanta Healthcare - Appointment Of Investor Relation (IR) Agency

    10 Jan 2026, 11:29AM Appointment of Investor Relation (IR) Agency
  • Amanta Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jan 2026, 2:19PM Amanta Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Amanta Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2026, 2:22PM certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
  • Amanta Healthcare - Agreements

    2 Jan 2026, 5:05PM Amanta Healthcare Limited has informed the Exchange about Agreements
  • Amanta Healthcare - Announcement Under Regulation 30

    2 Jan 2026, 4:57PM Announcement under Regulation 30
  • Amanta Healthcare - Agreements

    30 Dec 2025, 3:36PM Amanta Healthcare Limited has informed the Exchange about Agreements
  • Amanta Healthcare - Announcement Under Regulation 30

    30 Dec 2025, 3:50PM Announcement under Regulation 30
  • Amanta Healthcare - Trading Window

    29 Dec 2025, 1:11PM Amanta Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations
  • Amanta Healthcare - Updates

    29 Nov 2025, 1:59PM Amanta Healthcare Limited has informed the Exchange regarding 'Change in CIN of Company'.
  • Amanta Healthcare - Change In CIN Of Company

    29 Nov 2025, 1:52PM Intimation for updation of CIN of the Company
  • Amanta Healthcare Q2 net profit down 46.46% at Rs 1.21 cr

    17 Nov 2025, 3:30PM The company reported standalone net profit of Rs 1.21 crore for the quarter ended September 30, 2025 as compared to Rs 2.26 crore in the same period l

Key fundamentals

Evaluate the intrinsic value of Amanta Healthcare Ltd stock 

Name March-25 March-24
Assets 291.3844 271.5179
Liabilities 291.3844 271.5179
Equity 28.8294 26.8294
Gross Profit 59.6685 57.49
Net Profit 10.5007 3.6332
Cash From Operating Activities 46.62 58.073
NPM(%) 3.82 1.29
Revenue 274.7082 280.3403
Expenses 215.0397 222.8503
ROE(%) 4.98 1.72

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Amanta Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 734.25 -0.23 43.60 59.41 301.39 0.68
Lotus Eye Hospital and Institute Ltd 124.00 4.44 400.00 216.49 3.55 0.00
Vaishali Pharma Ltd 7.92 -1.74 0.00 1358.11 3.13 0.00
Astec Lifesciences Ltd 642.60 3.12 0.00 204.15 -604.77 0.00

Company Info

Our Company was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership firm "Marck Parenterals (India)" under Part IX of the Companies Act, 1956 and received the Certificate for Commencement of Business on January 06, 1995. The name of our Company was changed to "Marck Biosciences Limited" pursuant to a special resolution passed by our shareholders on October 29, 2005, and a fresh certificate of incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005. Subsequently, the name of our Company was changed to "Amanta Healthcare Limited" pursuant to a special resolution passed by our shareholders on June 12, 2014, and a fresh certificate of incorporation dated June 24, 2014 issued by the Registrar of Companies, Gujarat, at Ahmedabad.Major Events and Milestones:1994- Converted in a Public Limited Company1997- Started implementation of Large Volume Parenterals (LVP) project for Formulations, Fluid Therapy & Irrigation Solution1998- Commencement of L-1 in Block A2002- Launched a specialised production line "LVP Line II" for the manufacture of Large Volume Parenterals in Kheda, Gujarat2005- Launched a specialised production line "SVP Line I" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.2007- Added L-III Large Volume Parenterals Facility for 500 ml products in Block -A2008- Launched a specialised production line "SVP line II" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.- Approval from The National Pharmaceutical Control Bureau - Malaysia (a PIC member)2021- Launched a specialised production line "SteriPort -Debottlenecking"2023- Received WHO- GMP certification for Manufacturing facility at Kheda, Gujarat2024- Got CE Mark Certification for Eye Wash Solutions- Manufacturing out of seven (7) active production lines including SVP and LVP- Granted permission to manufacture and market the product named Linezolid I.V. injection (Domestic)

Our Company was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership firm "Marck Parenterals (India)" under Part IX of the Companies Act, 1956 and received the Certificate for Commencement of Business on January 06, 1995. The name of our Company was changed to "Marck Biosciences Limited" pursuant to a special resolution passed by our shareholders on October 29, 2005, and a fresh certificate of incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005. Subsequently, the name of our Company was changed to "Amanta Healthcare Limited" pursuant to a special resolution passed by our shareholders on June 12, 2014, and a fresh certificate of incorporation dated June 24, 2014 issued by the Registrar of Companies, Gujarat, at Ahmedabad.Major Events and Milestones:1994- Converted in a Public Limited Company1997- Started implementation of Large Volume Parenterals (LVP) project for Formulations, Fluid Therapy & Irrigation Solution1998- Commencement of L-1 in Block A2002- Launched a specialised production line "LVP Line II" for the manufacture of Large Volume Parenterals in Kheda, Gujarat2005- Launched a specialised production line "SVP Line I" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.2007- Added L-III Large Volume Parenterals Facility for 500 ml products in Block -A2008- Launched a specialised production line "SVP line II" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.- Approval from The National Pharmaceutical Control Bureau - Malaysia (a PIC member)2021- Launched a specialised production line "SteriPort -Debottlenecking"2023- Received WHO- GMP certification for Manufacturing facility at Kheda, Gujarat2024- Got CE Mark Certification for Eye Wash Solutions- Manufacturing out of seven (7) active production lines including SVP and LVP- Granted permission to manufacture and market the product named Linezolid I.V. injection (Domestic)

Read More

Parent Organisation

Amanta Healthcare Ltd.

Founded

21/12/1994

Managing Director

Mr.Bhavesh Patel

NSE Symbol

AMANTAEQ

FAQ

The current price of Amanta Healthcare Ltd is ₹ 108.39.

The 52-week high for Amanta Healthcare Ltd is ₹ 109.00 and the 52-week low is ₹ 103.11.

The market capitalization of Amanta Healthcare Ltd is currently ₹ 420.87. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Amanta Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Amanta Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Amanta Healthcare Ltd shares.

The CEO of Amanta Healthcare Ltd is Mr.Bhavesh Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT